157 related articles for article (PubMed ID: 18607871)
1. Fracture risk in patients with different types of cancer.
Vestergaard P; Rejnmark L; Mosekilde L
Acta Oncol; 2009; 48(1):105-15. PubMed ID: 18607871
[TBL] [Abstract][Full Text] [Related]
2. Pathologic fractures correlate with reduced survival in patients with malignant bone disease.
Saad F; Lipton A; Cook R; Chen YM; Smith M; Coleman R
Cancer; 2007 Oct; 110(8):1860-7. PubMed ID: 17763372
[TBL] [Abstract][Full Text] [Related]
3. Fracture risk in Danish men with prostate cancer: a nationwide register study.
Abrahamsen B; Nielsen MF; Eskildsen P; Andersen JT; Walter S; Brixen K
BJU Int; 2007 Oct; 100(4):749-54. PubMed ID: 17822455
[TBL] [Abstract][Full Text] [Related]
4. Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancer.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2008 May; 82(5):334-40. PubMed ID: 18463912
[TBL] [Abstract][Full Text] [Related]
5. Fracture risk in users of oral anticoagulants: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
Int J Cardiol; 2007 Jun; 118(3):338-44. PubMed ID: 17055083
[TBL] [Abstract][Full Text] [Related]
6. Fracture risk in patients treated with loop diuretics.
Rejnmark L; Vestergaard P; Mosekilde L
J Intern Med; 2006 Jan; 259(1):117-24. PubMed ID: 16336519
[TBL] [Abstract][Full Text] [Related]
7. Fracture risk associated with the use of morphine and opiates.
Vestergaard P; Rejnmark L; Mosekilde L
J Intern Med; 2006 Jul; 260(1):76-87. PubMed ID: 16789982
[TBL] [Abstract][Full Text] [Related]
8. Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from Denmark.
Vestergaard P; Rejnmark L; Mosekilde L
Scand J Public Health; 2006; 34(4):371-7. PubMed ID: 16861187
[TBL] [Abstract][Full Text] [Related]
9. Fracture risk in patients with monoclonal gammopathy of undetermined significance.
Gregersen H; Jensen P; Gislum M; Jørgensen B; Sørensen HT; Nørgaard M
Br J Haematol; 2006 Oct; 135(1):62-7. PubMed ID: 16925792
[TBL] [Abstract][Full Text] [Related]
10. Reduced relative risk of fractures among users of lithium.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2005 Jul; 77(1):1-8. PubMed ID: 16007481
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptive use and risk of fractures.
Vestergaard P; Rejnmark L; Mosekilde L
Contraception; 2006 Jun; 73(6):571-6. PubMed ID: 16730486
[TBL] [Abstract][Full Text] [Related]
12. Fracture risk associated with parkinsonism and anti-Parkinson drugs.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2007 Sep; 81(3):153-61. PubMed ID: 17705047
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2006 Aug; 79(2):76-83. PubMed ID: 16927047
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2009 Jan; 84(1):45-55. PubMed ID: 19067021
[TBL] [Abstract][Full Text] [Related]
15. Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2005 Sep; 77(3):139-44. PubMed ID: 16151671
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate, azathioprine, cyclosporine, and risk of fracture.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2006 Aug; 79(2):69-75. PubMed ID: 16927044
[TBL] [Abstract][Full Text] [Related]
17. Fracture risk associated with systemic and topical corticosteroids.
Vestergaard P; Rejnmark L; Mosekilde L
J Intern Med; 2005 Apr; 257(4):374-84. PubMed ID: 15788008
[TBL] [Abstract][Full Text] [Related]
18. Fracture risk from psychotropic medications: a population-based analysis.
Bolton JM; Metge C; Lix L; Prior H; Sareen J; Leslie WD
J Clin Psychopharmacol; 2008 Aug; 28(4):384-91. PubMed ID: 18626264
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen use and osteoporotic fracture risk: a population-based analysis.
Cooke AL; Metge C; Lix L; Prior HJ; Leslie WD
J Clin Oncol; 2008 Nov; 26(32):5227-32. PubMed ID: 18838712
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy.
Sekine I; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
Lung Cancer; 2009 Aug; 65(2):219-22. PubMed ID: 19081161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
